NCT00518245 - Ischemia Driven Enoxaparin Therapy in ACS Presenting as Low Risk (IDEAL) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

March 31, 2009

Study Completion Date

August 31, 2009

Conditions

Unstable Angina

Interventions

DRUG

enoxaparin

Enoxaparin will be given subcutanteously at a dose of 1mg/kg every 12 hours for a minimum of 48 hours (4 doses) and a maximum of 8 days until a diagnostic / therapeutic procedure is performed, or at the discretion of the investigator.

Trial Locations (1)

M5B 1W8

St. Michael's Hospital, Toronto